Sugi Predict

Sugi Predict / Compounds / SCHEMBL4340438

SCHEMBL4340438

SCHEMBL4340438

NC(=S)N/N=C/c1cc(F)c(N2CC[C@@H](NCc3ccccc3Cl)C2)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TMEM97 Q5BJF2 1/20 0.42
▸ SIGMAR1 Q99720 1/20 0.42
▸ MAOB P27338 2/20 0.41
▸ KDM4E B2RXH2 4/20 0.40
▸ HTT P42858 3/20 0.40
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ ALOX12 P18054 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ GRM2 Q14416 2/20 0.36
▸ GRM3 Q14832 2/20 0.36
▸ BCHE P06276 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ BACE1 P56817 1/20 0.36
▸ GAA P10253 3/20 0.35
▸ HCRTR1 O43613 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4338115 1.00 TMEM97 (0.42) TMEM97SIGMAR1MAOBKDM4EHTT
SCHEMBL4338112 1.00 TMEM97 (0.42) TMEM97SIGMAR1MAOBKDM4EHTT
SCHEMBL4340441 1.00 TMEM97 (0.42) TMEM97SIGMAR1MAOBKDM4EHTT
SCHEMBL4329133 0.96 MAOB (0.42) TMEM97SIGMAR1MAOBKDM4EHTT
SCHEMBL4329130 0.96 MAOB (0.42) TMEM97SIGMAR1MAOBKDM4EHTT
SCHEMBL4331977 0.92 MAOB (0.46) TMEM97SIGMAR1MAOBKDM4EHTT
SCHEMBL4326985 0.92 MAOB (0.46) TMEM97SIGMAR1MAOBKDM4EHTT
SCHEMBL4326990 0.92 MAOB (0.46) TMEM97SIGMAR1MAOBKDM4EHTT
SCHEMBL4325230 0.92 MAOB (0.46) TMEM97SIGMAR1MAOBKDM4EHTT
SCHEMBL4323973 0.91 TMEM97 (0.45) TMEM97SIGMAR1MAOBKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090285849-A1 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2009-11-19 — — US disclosed
US-20090285849-A1 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2009-11-19 — — US disclosed
US-20090285849-A1 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2009-11-19 — — US disclosed
US-7521062-B2 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) 2009-04-21 — — US disclosed
US-7521062-B2 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) 2009-04-21 — — US disclosed
US-7521062-B2 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) 2009-04-21 — — US disclosed
US-20050069555-A1 Thiosemicarbazones as anti-virals and immunopotentiators NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2005-03-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090285849-A1 Thiosemicarbazones as anti-virals and immunopotentiators MAVS, IRF3, HAVCR2 TMEM97 784/4885SIGMAR1 948/4885MAOB 2762/4885
US-20050069555-A1 Thiosemicarbazones as anti-virals and immunopotentiators MAVS, IRF3, HAVCR2 TMEM97 720/4885SIGMAR1 776/4885MAOB 3093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.